Lista de obras - José A. Carrión - Dominio Público Uruguay

A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.

artículo científico publicado en 2013

Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH

scientific article published on 23 November 2019

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.

artículo científico publicado en 2008

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

artículo científico publicado en 2017

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

artículo científico publicado en 2015

Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators

artículo científico publicado en 2014

Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis

artículo científico publicado en 2015

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation

artículo científico publicado en 2012

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

artículo científico publicado en 2018

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

artículo científico publicado en 2019

Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years

artículo científico publicado en 2016

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

artículo científico publicado en 2018

Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.

artículo científico publicado en 2011

Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.

artículo científico publicado en 2014

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

artículo científico publicado en 2018

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

artículo científico publicado en 2016

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

artículo científico publicado en 2016

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

artículo científico publicado en 2018

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

artículo científico publicado en 2007

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

artículo científico publicado en 2018

Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy

artículo científico publicado en 2011

Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation.

artículo científico publicado en 2007

Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection.

artículo científico publicado en 2017

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

scientific article published on 01 August 2018

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

article

Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.

artículo científico publicado en 2013

Hepatic elastography. Position paper of the Catalan Society of Gastroenterology

artículo científico publicado en 2011

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

artículo científico publicado en 2006

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen

artículo científico publicado en 2017

Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.

artículo científico publicado en 2009

Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains.

artículo científico publicado en 2010

Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients.

artículo científico publicado en 2017

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients

scientific article published on 06 September 2019

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

artículo científico publicado en 2004

Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct-acting antiviral therapy-authors' reply

artículo científico publicado en 2017

Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.

artículo científico publicado en 2014

Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation

artículo científico publicado en 2010

Living donor liver transplantation and hepatitis C: lessons from the learning curve?

artículo científico publicado en 2007

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

artículo científico publicado en 2016

Noninvasive tests in the post–liver transplantation setting

artículo científico publicado en 2007

Potential Drug-Drug Interactions of Ombitasvir, Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice.

artículo científico publicado en 2017

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.

artículo científico publicado en 2015

Predictive model of mortality in patients with spontaneous bacterial peritonitis.

artículo científico publicado en 2016

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

artículo científico publicado en 2017

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

scientific article published on 12 November 2019

Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care

artículo científico publicado en 2019

Retransplantation in patients with hepatitis C recurrence after liver transplantation

artículo científico publicado en 2010

Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection.

artículo científico publicado en 2006

Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.

artículo científico publicado en 2009

Severe acute hepatitis in the DRESS syndrome: Report of two cases.

artículo científico publicado en 2010

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

scientific article published on 20 January 2020

Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.

artículo científico publicado en 2015

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

artículo científico publicado en 2014

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules

scientific article published on 24 January 2019

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

artículo científico publicado en 2006

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

artículo científico publicado en 2017

Usefulness of tomographic computer colonography for colorectal polyp detection

artículo científico publicado en 2004

Utilidad de la colonografía por tomografía computarizada en la detección de pólipos colorrectales

artículo científico publicado en 2004

[Liver abscesses following liver transplantation from non-heart-beating donation]

artículo científico publicado en 2010

[Utility of Fibroscan in the evaluation of liver fibrosis]

artículo científico publicado en 2009

Lista de obras de José A. Carrión

A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.

Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators

Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.

Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy

Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation.

Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection.

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.

Hepatic elastography. Position paper of the Catalan Society of Gastroenterology

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen

Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.

Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains.

Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients.

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients

Large spontaneous splenorenal shunt as a cause of chronic hepatic encephalopathy

Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct-acting antiviral therapy-authors' reply

Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.

Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation

Living donor liver transplantation and hepatitis C: lessons from the learning curve?

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

Noninvasive tests in the post–liver transplantation setting

Potential Drug-Drug Interactions of Ombitasvir, Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice.

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.

Predictive model of mortality in patients with spontaneous bacterial peritonitis.

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care

Retransplantation in patients with hepatitis C recurrence after liver transplantation

Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection.

Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.

Severe acute hepatitis in the DRESS syndrome: Report of two cases.

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

Usefulness of tomographic computer colonography for colorectal polyp detection

Utilidad de la colonografía por tomografía computarizada en la detección de pólipos colorrectales

[Liver abscesses following liver transplantation from non-heart-beating donation]

[Utility of Fibroscan in the evaluation of liver fibrosis]